Active utilizations:

Monoclonal Antibodies: Specifically designed to bind to unique proteins on cancer cells.

Immune Modulators: Boost the immune response to attack cancer cells.

CRISPR-Cas9: Used to edit genes in cancer cells to induce apoptosis (cell death).
